Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

Genmab (GMABc)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,995.25 -6.75    -0.34%
03:14:48 - Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  DK0010272202 
  • Volume: 25
  • Bid/Ask: 1,981.50 / 2,019.00
  • Day's Range: 1,995.25 - 1,999.00
Genmab 1,995.25 -6.75 -0.34%

CSE:GMABc Financials

 
A brief overview of the CSE:GMAB financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Genmab over time.

Genmab A/S reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was DKK 16,474 million compared to DKK 14,505 million a year ago. Net income was DKK 4,352 million compared to DKK 5,452 million a year ago. Basic earnings per share from continuing operations was DKK 66.64 compared to DKK 83.38 a year ago. Diluted earnings per share from continuing operations was DKK 66.02 compared to DKK 82.59 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GMABc Income Statement

Gross margin TTM 98.63%
Operating margin TTM 32.3%
Net Profit margin TTM 26.42%
Return on Investment TTM 13.78%
 Total Revenue  Net Income
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Revenue 4744 4198 2854 5227
Gross Profit 4644 4198 2854 5227
Operating Income 1717 1497 437 2703
Net Income 2129 1357 226 584

GMABc Balance Sheet

Quick Ratio MRQ 13.32
Current Ratio MRQ 13.34
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 2.44%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Assets 35238 31978 30394 30278
Total Liabilities 4126 3223 3204 2837
Total Equity 31112 28755 27190 27441

GMABc Cash Flow Statement

Cash Flow/Share TTM 112.98
Revenue/Share TTM 252.2
Operating Cash Flow  70.19%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2037 436 3235 398
Cash From Investing Activities 1008 -1835 -13 -136
Cash From Financing Activities 20 7 -611 131
Net Change in Cash 3399 -1414 2395 -484
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GMAB Comments

Write your thoughts about Genmab
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mark Marriott
Mark Marriott Oct 27, 2021 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock worths buying for the long term?
The Note
TheNote Jul 26, 2021 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 3620 .. medium/long.Daily chart: https://invst.ly/vjgx1 Weekly chart: https://invst.ly/vjgxu
The Note
TheNote Jul 26, 2021 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cup with handle - emminent !!!https://www.proinvestor.com/boards/95471Translate from that site (from danish) into english.
BumHunters Archer
JohnJenga Mar 17, 2021 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NBI might roll over. Risky now
BumHunters Archer
JohnJenga Mar 07, 2021 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1992 indicative price vs 1901 close dk and 1970 close us
BumHunters Archer
JohnJenga Mar 07, 2021 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2200 this week possible, imo
BumHunters Archer
JohnJenga Mar 04, 2021 5:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice correction - but have more or less only removed dec7jan baboon buys
Martin Lynge
Martin Lynge Mar 04, 2021 5:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You mean since June last year.. .. Giant sell out...
Martin Lynge
Martin Lynge Jun 27, 2019 2:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
US 1st line approval this evening... 1200+ tomorrow?
Michael Almskov
Michael Almskov Jun 27, 2019 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=f7f1738b-beb1-47b2-a9dc-ab402ccd42e9
Michael Almskov
Michael Almskov Jun 19, 2019 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Blackrock now owns 5% of the shares in genmab
Martin Lynge
Martin Lynge Feb 25, 2019 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interesting to see, if we go beyond 1120 this time...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email